<DOC>
	<DOC>NCT00002229</DOC>
	<brief_summary>The purpose of this study is to see if it is safe and effective to give saquinavir (as a soft gel capsule taken by mouth) along with 2 other anti-HIV drugs to HIV-infected patients.</brief_summary>
	<brief_title>Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients</brief_title>
	<detailed_description>Prior to initiation of study treatment all patients are screened and baseline lab values are taken. Patients then receive the study treatment, FORTOVASE, two times a day plus 2 new NRTI's. Assessments will be performed at specified intervals throughout the duration of treatment.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Inclusion Criteria You may be eligible for this study if you: Are HIVpositive. Have an HIV count of 5,000 copies/ml or more. Have a CD4 count of 100 cells/mm3 or more. Meet specific requirements if you have ever taken NRTIs. Are 16 64 years old (need consent if under 18). Agree to use effective methods of birth control during the study. Exclusion Criteria You will not be eligible for this study if you: Have taken nonnucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors (PIs) for more than 2 weeks. Have taken all the available NRTIs. Have certain serious medical conditions, including severe liver disease or active opportunistic (AIDSrelated) infection. Have a history of weight loss, muscle pain, and loss of appetite. Have taken certain medications, including antiHIV drugs other than those required by this study. Are pregnant or breastfeeding. Abuse alcohol or drugs. Are unable to complete the study for any reason.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 1999</verification_date>
	<keyword>Drug Therapy, Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Dosage Forms</keyword>
	<keyword>Saquinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>